[Form 4] authID Inc. Insider Trading Activity
Michael L. Koehneman, a director of authID Inc. (AUID), reported changes in his beneficial ownership on Form 4. The filing shows a sale of 1,471 shares of common stock on 09/04/2025, leaving him with 29 shares beneficially owned indirectly through his wife, Karen Koehneman. The report also lists multiple outstanding stock options with varying exercise prices and terms.
Notably, an option grant exercisable on 09/04/2025 for 38,024 shares at an exercise price of $3.90 is reported as acquired on 09/04/2025 and vests monthly over 12 months. Other outstanding options total 44,716 shares across exercise prices from $5.48 to $121.28, all held directly.
- Large time‑based option grant: 38,024 options at $3.90 exercisable 09/04/2025 with monthly vesting over 12 months, indicating retention alignment
- Full disclosure of multiple option grants and indirect ownership through spouse, meeting Section 16 reporting requirements
- Share disposal: Sale of 1,471 common shares on 09/04/2025 (reduces direct shareholdings to 29 held indirectly)
- Potential dilution: Aggregate outstanding options (38,024 + 44,716) represent future common shares if exercised
Insights
TL;DR: Director sold a small lot of shares and holds meaningful option positions, including a large grant vesting over 12 months.
The transaction shows a modest sale of 1,471 common shares while the director retains substantial option exposure: a newly reported 38,024-share option at $3.90 exercisable 09/04/2025 plus roughly 44,716 additional options across prior grants. The vesting schedule (monthly over 12 months) ties realized value to continued service or time, which is relevant when modeling potential future dilution or insider incentives. No convertible securities or exercised-to-cash events are disclosed.
TL;DR: Disclosure is routine under Section 16; sale size is small but option grants indicate alignment with company performance/time-based vesting.
The Form 4 complies with reporting requirements and documents both a small share disposition and multiple option holdings. The 12-month monthly vesting clause for the largest option grant suggests a time-based retention incentive rather than immediate realized gain. There are no disclosures of related-party or unusual transaction codes that would signal governance concerns.